| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |